Ibrutinib, a Bruton's tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity

Ibrutinib, a Bruton's tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Allergy and Clinical Immunology - Volume 140, Issue 3, September 2017, Pages 875-879.e1

Jennifer A. MD, PhD, Yun MD, Melanie C. MD, PhD, Shuo MD, PhD, Leo I. MD, Adam M. MD, Bruce S. MD,